Codes / ICD10CM / N42.32

N42.32 Atypical small acinar proliferation of prostate

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Atypical small acinar proliferation of prostate

Summary

Atypical small acinar proliferation (ASAP) of the prostate is a histopathological finding characterized by small glandular structures in prostate tissue that show cellular abnormalities but do not meet the criteria for a definitive cancer diagnosis. This condition is often identified during prostate biopsies and may indicate a precancerous or atypical process requiring further evaluation.

Causes

The exact causes of ASAP are not fully understood, but it may result from genetic mutations, hormonal influences, or chronic inflammatory changes in prostate tissue. These cellular abnormalities can arise as part of the natural aging process or in response to underlying prostate conditions.

Risk Factors

  • Age, particularly men over 50
  • Prior prostate biopsies showing cellular changes
  • Family history of prostate cancer
  • Elevated prostate-specific antigen (PSA) levels
  • History of prostatitis or other prostate inflammation

Symptoms

  • No symptoms may be present in early stages
  • Urinary changes, such as increased frequency or difficulty urinating
  • Pelvic discomfort or pain
  • Abnormal findings during routine prostate examinations

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, including a digital rectal exam (DRE), and imaging studies like transrectal ultrasound (TRUS) or MRI. A prostate biopsy is performed to evaluate cellular changes, and additional biopsies may be recommended to rule out malignancy.

Treatment Options

  • Active surveillance with regular monitoring
  • Repeat prostate biopsy to assess for cancer
  • Consultation with a urologist for further management

Prognosis and Follow-Up

Prognosis depends on follow-up biopsy results. Many cases of ASAP do not progress to cancer, but regular monitoring is essential. Follow-up care may include periodic PSA testing, imaging, and repeat biopsies as determined by a healthcare provider.

Complications

  • Potential progression to prostate cancer if left unmonitored
  • Anxiety or stress related to diagnostic uncertainty
  • Need for additional medical procedures (e.g., repeat biopsies)

Lifestyle & Prevention

  • Maintain a healthy diet rich in fruits and vegetables
  • Engage in regular physical activity
  • Avoid smoking and limit alcohol consumption
  • Discuss prostate health screening with a healthcare provider based on individual risk factors

When to Seek Professional Help

Seek medical attention if you experience persistent urinary symptoms, pelvic pain, or notice blood in urine or semen. Prompt evaluation is recommended if you have a family history of prostate cancer or elevated PSA levels.

Tips for Medical Coders

Document the clinical context, including biopsy results and follow-up plans, to support coding for atypical small acinar proliferation. Ensure documentation aligns with the histopathological findings and any associated diagnostic workup.

Book a walkthrough

N42.32 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.